[Clinical trial of a portable insulin dosage pump].
The wearable drug pump HDL-2M has been clinically tested. It is of small dimensions, high reliability and easy-to-use. By means of the unit insulin was administered to patients suffering from insulin-dependent diabetes mellitus. With the HDL-2M, the therapy of the diabetes has been shown to be more effective than the traditional hypodermic injections because it allows a rapid glycemia normalization with less insulin dosage, as a rule, and a considerable decrease in glycemia lability. The numerous tests demonstrate that the HDL-2M can be extensively and successfully used for therapy of insulin-dependent diabetes mellitus in clinical practice.